Sohini Das

Stories by Sohini Das

Medical devices to be treated as drugs from next fiscal

Medical devices to be treated as drugs from next fiscal

Rediff.com   12 Feb 2020

The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of compliance.

Coronavirus: Windfall likely for medical device firms

Coronavirus: Windfall likely for medical device firms

Rediff.com   7 Feb 2020

As fear grips the world, demand for protective gear used by health care professionals and citizens is on a rise. And, supply disruption from China has opened a window of opportunities for Indian medical device makers.

Adamant Trai says will implement new tariff order by March 1

Adamant Trai says will implement new tariff order by March 1

Rediff.com   14 Jan 2020

Reiterating its position, TRAI, which oversees both the telecom and television sectors in the country, said the amendments suggested on January 1 had been done to correct "distortions" in the market and address pricing issues.

Price relief for diabetes patients as drugs go off patent

Price relief for diabetes patients as drugs go off patent

Rediff.com   13 Jan 2020

At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.

How Avengers stole the Indian box office

How Avengers stole the Indian box office

Rediff.com   1 Jan 2020

'If you look at the Number 1 film in India this year across Bollywood and other regional film industries, it is Avengers: Endgame.'

What is the future of e-pharmacies in India?

What is the future of e-pharmacies in India?

Rediff.com   19 Dec 2019

PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.

How govt plans to ensure faster availability of new drugs

How govt plans to ensure faster availability of new drugs

Rediff.com   16 Dec 2019

Concerned about the rise of antibiotic resistance and the time it takes for drugs developed abroad to reach Indians, the government is considering holding its own clinical trials. Clinical trials for new drugs have so far primarily been conducted only by private Indian or foreign drug firms. But given the stringent nature of India's regulatory environment for clinical trials, several pharmaceutical companies have moved their trials out of India. As a result, only 1.2 per cent of global clinical trials take place in India.

How govt plans to buy med devices cheaply for Ayushman

How govt plans to buy med devices cheaply for Ayushman

Rediff.com   15 Dec 2019

According to a senior government official, the plan is to do "collective bargaining" for certain medical devices and implants by assuring a bulk requirement to the manufacturers. "The requirement for these devices runs into millions. We assure them that the requirement is going to be in bulk. In return, they should offer us better rates," he said.

Why prices of vitamin C, antibiotics could shoot up

Why prices of vitamin C, antibiotics could shoot up

Rediff.com   14 Dec 2019

The government said that "in exercise of extraordinary powers in public interest, conferred by paragraph 19 of the DPCO, 2013", the ceiling prices of 21 key formulations had been increased. These formulations include common medicines like BCG vaccines, penicillin, malaria and leprosy medicines (Dapsone), life-saving drugs like Furosemide (used to treat fluid build-up due to heart failure, liver scarring, or kidney disease), vitamin C, some common antibiotics, and anti-allergy medicines.

Lupin sells Japan arm to Unison for Rs 3,702 cr

Lupin sells Japan arm to Unison for Rs 3,702 cr

Rediff.com   12 Nov 2019

The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India.

Online ticket sales a bonanza for multiplexes

Online ticket sales a bonanza for multiplexes

Rediff.com   31 Oct 2019

Revenue from convenience fees has grown at a compound annual rate of 85 per cent for multiplex chain operator Inox Leisure and 58 per cent for PVR.

Govt may now cap prices of antibiotics

Govt may now cap prices of antibiotics

Rediff.com   7 Oct 2019

The intention of the government is to cap prices of drugs that are essential and which the public widely uses.

DRL, 1st Indian company to supply generic drugs to China's state hospitals

DRL, 1st Indian company to supply generic drugs to China's state hospitals

Rediff.com   27 Sep 2019

The drug that it would supply is called Olanzapine, used to treat schizophrenia and bipolar disorder.

GSK withdraws sale of Zinetac after health alert

GSK withdraws sale of Zinetac after health alert

Rediff.com   26 Sep 2019

GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

Drones will deliver critical drugs at your doorstep

Drones will deliver critical drugs at your doorstep

Rediff.com   17 Sep 2019

Maharashtra govt, California-based Zipline to launch the automated delivery service funded by Serum Institute.

Airtel beats Vodafone Idea to become India's No 2 telco

Airtel beats Vodafone Idea to become India's No 2 telco

Rediff.com   6 Aug 2019

What worked for Airtel was that its data traffic growth was 13 per cent sequentially and its average data usage was even higher than Jio's at 11.9 gigabyte per month per user.

Why JioPhone is no more popular in Bharat

Why JioPhone is no more popular in Bharat

Rediff.com   5 Aug 2019

Used smartphones are gaining popularity in the hinterland, the main market for JioPhone. Share of JioPhone in the feature phone market had shrunk from 47% in Q2 of 2018 to 28% a year after.

Sun Pharma's Dilip Shanghvi takes 99% pay cut

Sun Pharma's Dilip Shanghvi takes 99% pay cut

Rediff.com   2 Aug 2019

As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore.

India's rural mobile phone base slips further

India's rural mobile phone base slips further

Rediff.com   26 Jun 2019

According to telcos and analysts, this is due to SIM consolidation happening after the minimum recharge plans were implemented by incumbents.

Despite cap on pricing import of medical devices rises

Despite cap on pricing import of medical devices rises

Rediff.com   24 Jun 2019

The growth in imports was led by product categories such as diagnostic items, ultra-sonogram machines, MRI and ECG apparatus, syringes with needles, suture needles, digital thermometers, malaria diagnostic kits, and hearing aids.